methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]

RxCUI
207193
RxNorm name
methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]
Display name
SOLU-Medrol (Injectable)
Full name
methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]
Term type
SBD
Status
Active
Strength
62.5 mg/ml
Dose form
Sol
Route
Injectable
Updated
2026-11-08 10:18:24

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methylprednisolone sodium succinate62.5 MG / 1 MLmethylprednisolonemethylprednisolone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injectable Solution316949

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methylprednisolone6902

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRSOLU-Medrol 62.5 MG/ML Injectable Solution1NAMES
RxNorm Namemethylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI2071931CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0009-0698-010009-0698SOLU-MEDROL methylprednisolone sodium succinatePharmacia & Upjohn Company LLCNDA011856
0009-0698-020009-0698SOLU-MEDROL methylprednisolone sodium succinatePharmacia & Upjohn Company LLCNDA011856
0009-0758-010009-0758SOLU-MEDROL methylprednisolone sodium succinatePharmacia & Upjohn Company LLCNDA011856

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0118560009-0698SOLU-MEDROL methylprednisolone sodium succinateNDAPharmacia & Upjohn Company LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 30 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00009069801rxnav_ndcsyes
00009069802rxnav_ndcsyes
00009075801rxnav_ndcsyes
00009004722rxnav_historical
00009004725rxnav_historical
00009004726rxnav_historical
00009004727rxnav_historical
00009004733rxnav_historical
00009019009rxnav_historical
00009019010rxnav_historical
00009019016rxnav_historical
00009019022rxnav_historical
00009076502rxnav_historical
00009088701rxnav_historical
00247068302rxnav_historical
12280023201rxnav_historical
52584019009rxnav_historical
54569155500rxnav_historical
54569155501rxnav_historical
54868362300rxnav_historical
54868363700rxnav_historical
54868363701rxnav_historical
55045350901rxnav_historical
55045350902rxnav_historical
55154391505rxnav_historical
55154391507rxnav_historical
58016945201rxnav_historical
62584045445rxnav_historical
64579008201rxnav_historical
68788067101rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEPharmacia & Upjohn Company LLC7271310c-7764-4812-aa30-a5e90987c7a92026-06-25Warnings, Adverse reactionsExact identifier
ndc (package): 0009-0698-02
ndc (product): 0009-0698
ndc11 (package): 00009069802
rxcui: 207193
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEPharmacia & Upjohn Company LLCcd99be87-c8d9-48d6-a8e5-e081052e3f192025-12-02Warnings, Adverse reactionsExact identifier
ndc (package): 0009-0758-01
ndc (package): 0009-0698-01
ndc (product): 0009-0758
ndc (product): 0009-0698
ndc11 (package): 00009004727
ndc11 (package): 00009004726
ndc11 (package): 00009004722
ndc11 (package): 00009004725
ndc11 (package): 00009075801
ndc11 (package): 00009069801
rxcui: 207193

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cd99be87-c8d9-48d6-a8e5-e081052e3f19SOLU-Medrol 62.5 MG/ML Injectable Solution [PSN] · methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] [SBD] · Solu-Medrol (as methylprednisolone sodium succinate) 62.5 MG/ML Injectable Solution [SY] · Solu-Medrol 62.5 MG/ML Injectable Solution [SY]435SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)20251202
7271310c-7764-4812-aa30-a5e90987c7a9SOLU-Medrol 62.5 MG/ML Injectable Solution [PSN] · methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] [SBD] · Solu-Medrol (as methylprednisolone sodium succinate) 62.5 MG/ML Injectable Solution [SY] · Solu-Medrol 62.5 MG/ML Injectable Solution [SY]411SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)20251203

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
7271310c-7764-4812-aa30-a5e90987c7a9SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20260625
7271310c-7764-4812-aa30-a5e90987c7a9SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20251203
cd99be87-c8d9-48d6-a8e5-e081052e3f19SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20251202
7271310c-7764-4812-aa30-a5e90987c7a9SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20251125
cd99be87-c8d9-48d6-a8e5-e081052e3f19SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20251124
7271310c-7764-4812-aa30-a5e90987c7a9SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20250730
cd99be87-c8d9-48d6-a8e5-e081052e3f19SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP)Pharmacia & Upjohn Company LLC20250513
1ae6fb26-76b3-40a2-938e-0d2fb48a08f8National Council for Prescription Drug Programs20130502
1d279bcb-0bbb-4c7c-a077-0b19a114c75aNational Council for Prescription Drug Programs20130213
7bfba518-8122-45f4-8b32-7380abc4a0efNational Council for Prescription Drug Programs20130213
7029e370-6384-4c2a-abc3-0c5ef722842bNational Council for Prescription Drug Programs20120724
8a9fca70-b985-4d56-ab2c-b677f4421450National Council for Prescription Drug Programs20120724
a6bb9d8e-775e-414b-a78c-e9be34f72b91National Council for Prescription Drug Programs20120724
b2173d6d-279e-4bf1-8c37-2b83881083a4National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AACorticosteroids, combinations for treatment of acneATC1-4methylprednisolone
ATCD07AACorticosteroids, weak (group I)ATC1-4methylprednisolone
ATCH02ABGlucocorticoidsATC1-4methylprednisolone
FDASPLN0000175576CorticosteroidEPChas_epcmethylprednisolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTD008775MethylprednisoloneCHEMhas_ingredientmethylprednisolone
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone
MEDRTD007223InfantDISEASEci_withmethylprednisolone
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone
MEDRTD009181MycosesDISEASEci_withmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH62.5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA011856
NAMESPrescribable SynonymSOLU-Medrol 62.5 MG/ML Injectable Solution
NAMESTallman SynonymmethylPREDNISolone 62.5 MG/ML Injectable Solution [SOLU-Medrol]
NAMESTallman SynonymSOLU-Medrol (as methylPREDNISolone sodium succinate) 62.5 MG/ML Injectable Solution
NAMESTallman SynonymSOLU-Medrol 62.5 MG/ML Injectable Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon